HAMP and ovarian carcinoma: In the present study, six biomarkers (miRNA-204, CA125, CA19.9, hepcidin, microfibril-associated glycoprotein 2, and FPN1) were screened for the early diagnosis of ovarian cancer and the role of miRNA-204 in ovary carcinogenesis was determined.